CD42b
Aliases: | BDPLT1, BDPLT3, BSS, CD42B, CD42b-alpha, DBPLT3, GP1B, GPIbA, GPIbalpha, VWDP |
---|---|
Other: | platelet glycoprotein Ib alpha chain|GP-Ib alpha|antigen CD42b-alpha|glycoprotein Ib (platelet), alpha polypeptide|glycoprotein Ib platelet alpha subunit|mutant platelet membrane glycoprotein Ib-alpha|platelet membrane glycoprotein 1b-alpha subunit|platelet membrane glycoprotein Ib-alpha |
Glycoprotein Ib (GP Ib) is a platelet surface membrane glycoprotein composed of a heterodimer, an alpha chain and a beta chain, that is linked by disulfide bonds. The Gp Ib functions as a receptor for von Willebrand factor (VWF). The complete receptor complex includes noncovalent association of the alpha and beta subunits with platelet glycoprotein IX and platelet glycoprotein V. The binding of... see more
Brilliant Violet 421
Common Laser: | 405 |
---|---|
Common Filter: | 450/50 |
Excitation Peak: | 405 |
Emission Peak: | 421 |
Brilliant™ Violet 421 (BV421) is a Violet-emitting non-tandem polymer fluorophore that can be excited by the 405 nm Violet laser and collected using a 450/50 bandpass filter. BV421 has an excitation peak at 405 nm and an emission peak at 421 nm, and is spectrally similar to Alexa Fluor™ 405 and Cascade Blue. Other dyes that are considered similar include SuperNova V428 (Beckman Coulter), StarBr... see more
Popular CD42b Brilliant Violet 421 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
Sony 2119650 |
FC | CD42b Human,Chimpanzee |
Mouse IgG1 κ HIP1 |
100 Tests $439 |
Details | |
Sony 2119645 |
FC | CD42b Human,Chimpanzee |
Mouse IgG1 κ HIP1 |
25 Tests $174 |
Details | |
BioLegend 303929 |
FC | CD42b Human,Chimpanzee |
Mouse IgG1 κ HIP1 |
25 Tests $165 |
Details | |
BD Biosciences 740075 |
FC | CD42b Human |
Mouse IgG1 κ HIP1 |
50 μg $495 |
Details | |
BioLegend 303930 |
FC | CD42b Human,Chimpanzee |
Mouse IgG1 κ HIP1 |
100 Tests $418 |
Details | |
Browse CD42b / Brilliant Violet 421 antibodies. |